Myeloid derived suppressor cells and autoimmunity

被引:61
|
作者
Boros, Peter [1 ]
Ochando, Jordi [2 ]
Zeher, Margit [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Surg, Recanati Miller Transplant Inst, New York, NY 10129 USA
[2] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10129 USA
[3] Univ Debrecen, Div Clin Immunol, Fac Med, H-4032 Debrecen, Hungary
关键词
Myeloid derived suppressor cells; Type; 1; diabetes; Rheumatoid arthritis; SLE; Inflammatory bowel disease; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; ACTIVATED MONOCYTES; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; MICE; DISEASE; MOUSE; DIFFERENTIATION;
D O I
10.1016/j.humimm.2016.05.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells are a heterogeneous group of immature myeloid cells with immunoregulatory function. When activated and expanded, these cells can suppress T cell functions via cell-to cell interactions as well as soluble mediators. Recent studies investigated the involvement of MDSC in autoimmune diseases. Some papers have described beneficial effect of MDSC during the course of autoimmune diseases, and suggest a potential role as a treatment option, while others failed to detect these effects. Their contributions to autoimmune diseases are not fully understood, and many questions and some controversies remain as to the expansion, activation, and inhibitory functions of MDSC. This review aims to summarize current knowledge of MDSC in autoimmune disorders. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:631 / 636
页数:6
相关论文
共 50 条
  • [31] Myeloid-derived Suppressor Cells in Sepsis
    van der Poll, Tom
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (03) : 256 - 258
  • [32] History of myeloid-derived suppressor cells
    James E. Talmadge
    Dmitry I. Gabrilovich
    Nature Reviews Cancer, 2013, 13 : 739 - 752
  • [33] Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
    Benjamin Knier
    Michael Hiltensperger
    Christopher Sie
    Lilian Aly
    Gildas Lepennetier
    Thomas Engleitner
    Garima Garg
    Andreas Muschaweckh
    Meike Mitsdörffer
    Uwe Koedel
    Bastian Höchst
    Percy Knolle
    Matthias Gunzer
    Bernhard Hemmer
    Roland Rad
    Doron Merkler
    Thomas Korn
    Nature Immunology, 2018, 19 : 1341 - 1351
  • [34] Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
    Knier, Benjamin
    Hiltensperger, Michael
    Sie, Christopher
    Aly, Lilian
    Lepennetier, Gildas
    Engleitner, Thomas
    Garg, Garima
    Muschaweckh, Andreas
    Mitsdoerffer, Meike
    Koedel, Uwe
    Hoechst, Bastian
    Knolle, Percy
    Gunzer, Matthias
    Hemmer, Bernhard
    Rad, Roland
    Merkler, Doron
    Korn, Thomas
    NATURE IMMUNOLOGY, 2018, 19 (12) : 1341 - +
  • [35] Myeloid suppressor cells (MSC): the impact of a novel regulatory network in autoimmunity
    Cexus, O
    Labrousse, D
    Badami, E
    Tan, LA
    Londei, M
    Quaratino, S
    IMMUNOLOGY, 2005, 116 : 70 - 70
  • [36] Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy
    Kapor, Suncica
    Radojkovic, Milica
    Santibanez, Juan F.
    ACTA HISTOCHEMICA, 2024, 126 (5-7)
  • [37] Polarization and reprogramming of myeloid-derived suppressor cells
    Yang, Wen-Chin
    Ma, Ge
    Chen, Shu-Hsia
    Pan, Ping-Ying
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2013, 5 (03) : 207 - 209
  • [38] Chemotherapeutic targeting of myeloid-derived suppressor cells
    Alizadeh, Darya
    Katsanis, Emmanuel
    Larmonier, Nicolas
    ONCOIMMUNOLOGY, 2014, 3 (01)
  • [39] Immune Suppression: The Hallmark of Myeloid Derived Suppressor Cells
    Haile, Lydia A.
    Greten, Tim F.
    Korangy, Firouzeh
    IMMUNOLOGICAL INVESTIGATIONS, 2012, 41 (6-7) : 581 - 594
  • [40] The role of myeloid derived suppressor cells in mycosis fungoides
    Pileri, Alessandro
    Agostinelli, Claudio
    Quaglino, Pietro
    Patrizi, Annalisa
    Pimpinelli, Nicola
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (07) : 1175 - 1176